Susan Hasty, Publisher
Table of Contents . . . July 6th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Drug Law Weekly | Other Publications
Aid of AIDS - Drugs given away by AIDS patients in U.S. prolong lives worldwide
American Medical Association - Doctors' group rejects proposal to soften "freebie" policy
Cellegy Pharmaceuticals, Inc. - U.S. patent issued for improved treatment of erectile dysfunction
Centers for Medicare & Medicaid Services - Venture capitalist calls for overhaul of reimbursement approvals process
Drug Discount Cards - Insurance plans off to quick start in enrollment of beneficiaries for drug card
HIV/AIDS Treatment - Sterile needle program eyed in Atlantic City, New Jersey
Kos Pharmaceuticals, Inc. - Kos obtains settlement for trademark infringement of Advicor
Labcyte, Inc. - Patents issued for acoustics to manipulate liquids
Legal Issues - Judge says personal responsibility requirement oversteps law
Memory Pharmaceuticals Corp. - Jzaneen A. Lalani named VP legal affairs
Prescription Drugs - Groups plan gatherings to praise, criticize drug card benefits
Protein Design Labs, Inc. - Therapeutics company announces executive appointments
Transplant Medicine - Japan rethinks transplantations ethics as patients look elsewhere for organs
Trimedyne, Inc. - U.S. patent covers laser devices for treatment of mitral valve regurgitation
University of California - Nucleonics licenses key promoter technology for use in RNAi applications
Adherex Technologies, Inc. - Exherin clinical data released
Advanced Viral Research Corp. - Results of AVR118 phase I/II clinical program presented at ASCO
Alfred I. duPont Hospital for Children - Diminished lung compliance found in nutritionally obese young rats
Allos Therapeutics, Inc. - Phase III trial data suggest some lung cancer patients may benefit from RSR13
American Pharmaceutical Partners - Results reported in trial of Abraxane for advanced breast cancer patients
American Society of Clinical Oncology - NSABP protocol C-06: Oral chemotherapy equally effective and tolerated
Anthrax - Researchers accidentally exposed to live deadly bacterium
Antisense Therapeutics Limited - Positive results reported from phase I trial of ATL-1102 for MS
Antoine Beclere Hospital - Severe infections plague acute alcoholic hepatitis patients given infliximab
AstraZeneca - Study investigates resistance to tamoxifen and possible way to reverse it
Biomira - Merck, KGaA, returns Theratope rights
Biotech Holdings - First Sucanon production order completed
Breast Cancer - Pharmacogenomics discussed at meeting as personalized breast cancer treatment
Bristol-Myers Squibb Company - Antipsychotic Abilify (aripiprazole) approved for marketing in Europe
Burdock Group - Generally recognized as safe (GRAS) system reviewed
CNRS Pierre Fabre - The small molecule ajoene influences tumor cells through proteosome modulation
CV Therapeutics, Inc. - Biopharmaceutical company sells $25M in convertible notes
Cancer Treatment - University of Connecticut planning to make cancer center one of nation's elite
CancerVax Corporation - Data released on Canvaxin in treatment of patients with Stage IV melanoma
Catholic University of the Sacred Heart, Rome - Priming with rhG-CSF enhances gemtuzumab-ozogamicin efficacy in AML
Cecil Clinic, Lausanne - Sirolimus-eluting coronary stents effective in routine clinical practice
Cell Genesys, Inc. - Final results of phase I/II trial of CG7870 reported
Centers for Disease Control & Prevention - Overall population immunity to measles in U.S. is 93%
Centocor - Trial demonstrates Remicade improved bone erosion scores
ChemGenex Therapeutics - Genotyping helps determine appropriate Quinamed dose in cancer study patients
Chinese University of Hong Kong - Urinary leukotriene E4 correlates with severity of atopic dermatitis in children
Chonnam National University, Gwangju - Leukemic/donor-DC pulsed with leukemic cell lysates effectively prime donor CTLs
Clouatre Consulting Group - New reports of toxicity from kava kava examined
Cornell University - Novel MS-based microdevice suitable for quantitative analysis
Creighton University - Hydroxycitric acid extract promotes weight loss
CytRx Corporation - Strategic deal for copolymer technologies with SynthRx closed
Dana Farber Cancer Institute - Clinicians have concerns about sharing clinical trial results with participants
Deakin University - Fat replacement in sausage reduces fat intake in men
Dendreon Corporation - Phase I study results demonstrate promising activity of APC8024 immunotherapy
Disease Outbreak - Whooping cough outbreak in Robertson County, Tennessee
Duke University - Toll-like receptor signals needed to reverse regulatory CD8 tolerance
ESP Pharma, Inc. - Agreement signed to develop IV terlipressin for Type 1 hepato-renal syndrome
Edward Jenner Institute Vaccine Research - N. meningitidis membrane vesicles elicited antibody responses in mice
Eli Lilly and Co. - Studying microvascular complications may lead to better screenings, treatment
Employee Health - New HMC programs target costly link between depression and low back pain
Endocyte Inc. - Folate-targeted immunotherapy may provide strategy to combat malignant disease
European League Against Rheumatism - Deficiencies in healthcare provision exposed
Exactech, Inc. - FDA clearance granted for U.S. distribution of bone cement products
Express Scripts - Patients on Cox-2 therapy who take aspirin possibly negate benefits
Federal University of Rio de Janeiro - Drug helps obese teens lose weight
Fukuyama Medical Laboratory Company - Epitope for antibodies inhibiting H. pylori urease characterized
Genentech, Inc. - Avastin, Tarceva combination yields initial promising results for cancers
Genentech, Inc. - Data from broad Avastin clinical trial program presented at ASCO meeting
IVAX Corp. - FDA grants approval of generic Ciprofloxacin tablets
Incara Pharmaceuticals Corp. - Company to initiate AEOL 10150 safety studies directly in patients with ALS
Mazor Surgical Technologies - U.S. FDA approves miniature robot for spinal procedures
Sicel Technologies, Inc. - Oncology products manufacturer names new president and chief operating officer
U.S. Food & Drug Administration - Incentives available for developing treatments for inborn errors
U.S. Food & Drug Administration - Macrophages release TNF-alpha and IL-12 in response to B. anthracis
U.S. Food & Drug Administration - Protein biomarker unique to Vibrio parahaemolyticus O3:K6 identified
West Nile - Health official fears monsoon could bring West Nile virus cases
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.